646 results on '"Sakuraba, Atsushi"'
Search Results
2. Which Patients Benefit from Biologic Agents to Prevent Disease Recurrence After Resection in Crohn’s Disease?
3. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes
4. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis
5. Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience
6. Which Patients Benefit from Biologic Agents to Prevent Disease Recurrence After Resection in Crohn’s Disease?
7. Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis
8. Bariatric Bypass Surgery Is a Risk Factor for Incomplete Colonoscopy Preparation
9. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
10. Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis
11. Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes
12. Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes
13. The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis
14. Risk of Cancers in Patients with Pediatric Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
15. Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease
16. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch–Anal Anastomosis in Pediatric Ulcerative Colitis
17. Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes
18. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis
19. Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis
20. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease
21. EUS-guided fiducial placement for GI malignancies: a systematic review and meta-analysis
22. Utility of video capsule endoscopy for longitudinal monitoring of Crohn’s disease activity in the small bowel: a prospective study
23. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease
24. Real-World Experience with Tofacitinib in IBD at a Tertiary Center
25. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease
26. Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis
27. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
28. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis
29. What Is the Best Possible Therapy for My Crohn’s Disease? State-of-the-Art Therapy for Newly Diagnosed Crohn’s Disease
30. Oral Mesalamine
31. Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn’s Disease and Effects of Natalizumab Therapy
32. Follow-Up of Patients With Ulcerative Colitis and Histological Normalization
33. Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
34. Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies
35. Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.
36. Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer.
37. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes
38. S1599 Diagnostic Performance of Linked Color Image (LCI) and Blue Laser Imaging (BLI) for the Diagnosis of Early Gastric Cancer: A Systematic Review and Meta-Analysis
39. Biologic Therapy of Crohn’s Disease: Infliximab
40. Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer
41. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients
42. Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
43. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis
44. Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review
45. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis
46. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn’s Disease
47. Rapid Onset of Inflammatory Bowel Disease after Receiving Secukinumab Infusion
48. The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer
49. Approach to Optimize Anti-TNF-α Therapy in Patients With IBD
50. DELAY IN FIRST SCREENING COLONOSCOPY IS ASSOCIATED WITH INCREASED RISK OF COLORECTAL ADENOMAS AND CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.